Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma

Human T cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T cell leukemia/lymphoma (ATL), HTLV-1 associated myelopathy (HAM/TSP), and of a number of inflammatory diseases with an estimated 10–20 million infected individuals worldwide. Despite a number of therapeutic approaches, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Francesca Marino-Merlo, Antonio Mastino, Sandro Grelli, Olivier Hermine, Ali Bazarbachi, Beatrice Macchi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2018-05-01
Schriftenreihe:Frontiers in Microbiology
Schlagworte:
HTLV-1
ATL
antiviral agents
biological therapy
targeted therapy
Online Zugang:http://journal.frontiersin.org/article/10.3389/fmicb.2018.00925/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge